Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Matsui

Showing results (811-820 of 839) with videos related to

Pageof 84
Sort By:
Hepatology (Baltimore, Md.)|July 1, 1996
Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinomaT Masaki, M Tokuda, M Ohnishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1997
[Trial of radiation and cisplatin, carboplatin combination chemotherapy for advanced cancer (W-platinum chemoradiotherapy]M Kato, S Akimoto, K Akimoto, et al.
British Journal of Cancer|March 20, 2014
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapyT Hamada, Y Nakai, H Yasunaga, et al.
Nucleic Acids Research|January 11, 2000
HUNT: launch of a full-length cDNA database from the Helix Research InstituteH T Yudate, M Suwa, R Irie, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
British Journal of Pharmacology|November 30, 2011
Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activityM Biffen, H Matsui, S Edwards, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusionsCarol Ann Huff, Ephraim J Fuchs, B Douglas Smith, et al.
Leukemia Research|September 14, 2016
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studiesKelly J Norsworthy, Eunpi Cho, Jyoti Arora, et al.
Blood Advances|December 16, 2017
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamideYvette L Kasamon, Richard F Ambinder, Ephraim J Fuchs, et al.
Pageof 84

Showing results (811-820 of 839) with videos related to

Sort By:
Pageof 84
Hepatology (Baltimore, Md.)|July 1, 1996
Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinomaT Masaki, M Tokuda, M Ohnishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1997
[Trial of radiation and cisplatin, carboplatin combination chemotherapy for advanced cancer (W-platinum chemoradiotherapy]M Kato, S Akimoto, K Akimoto, et al.
British Journal of Cancer|March 20, 2014
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapyT Hamada, Y Nakai, H Yasunaga, et al.
Nucleic Acids Research|January 11, 2000
HUNT: launch of a full-length cDNA database from the Helix Research InstituteH T Yudate, M Suwa, R Irie, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
British Journal of Pharmacology|November 30, 2011
Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activityM Biffen, H Matsui, S Edwards, et al.
Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusionsCarol Ann Huff, Ephraim J Fuchs, B Douglas Smith, et al.
Leukemia Research|September 14, 2016
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studiesKelly J Norsworthy, Eunpi Cho, Jyoti Arora, et al.
Blood Advances|December 16, 2017
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamideYvette L Kasamon, Richard F Ambinder, Ephraim J Fuchs, et al.
Pageof 84